Medical products manufacturer Bio-Rad Laboratories, Inc.BIO recently announced that the U.S. FDA has approved its latest D-100 System for HbA1c testing - a common blood test used to diagnose the ...
Life science research and clinical diagnostic testing company Bio-Rad Laboratories, Inc. 's BIO VARIANT II TURBO HbA 1c Kit - 2.0 recently received the U.S. Food and Drug Administration (FDA) ...
DUBLIN--(BUSINESS WIRE)--The "Global POC HbA1C Testing Market 2017-2021" report has been added to Research and Markets' offering. The global POC HbA1C testing market to grow at a CAGR of 8.60% during ...
Dublin, Feb. 22, 2018 (GLOBE NEWSWIRE) -- The "Hemoglobin A1c Monitoring - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate ...
Hosted on MSN
Bio-Rad Laboratories, Inc. (BIO) Launches New Instruments, Boosts Molecular Testing Reach
In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Bio-Rad Laboratories, Inc. stands amongst them. Bio-Rad Laboratories, Inc. (NYSE:BIO), a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback